Eagle Bay Advisors LLC United Therapeutics Corp Transaction History

Eagle Bay Advisors LLC

  • $170 Million
  • Q3 2024

A detailed history of Eagle Bay Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 44 shares of UTHR stock, worth $15,849. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44
Previous 44 -0.0%
Holding current value
$15,849
Previous $14,000 7.14%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$210.76 - $249.51 $9,273 - $10,978
44 New
44 $10,000

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email